In addition to their appointments to the board, Mr Benjamin has been appointed to serve on the company’s audit committee, and Mr Meyer has been appointed to serve on the company’s audit and compensation committees.
Mr Benjamin is a general partner of Advent Venture Partners, a venture capital management firm in London. Currently, Mr Benjamin serves on the board of directors and is the chairman of the audit committee of Orthofix International.
Mr Meyer has previously served as a member of the board of directors and audit, compensation and governance committees of Isotechnika, a biopharmaceutical company.
Paul Kennedy, president and CEO of Ivax, said: “With the additions of Benjamin and Meyer to our board of directors only weeks after the previously announced additions of Patrice Debregeas, Laurent Le Portz and myself, the board of directors of Ivax Diagnostics is now composed of some of the most well respected and seasoned members of the life sciences industry.”